搜索临床试验以:Triple Class Refractory (TCR)
总计14536个结果
-
Yonsei University完全的
-
Eyetech PharmaceuticalsPfizer终止
-
The Center for Rheumatic Disease, Allergy, & ImmunologyGrifols Therapeutics LLC完全的
-
University of Turin, Italy完全的
-
National Institute of CancerologíaNational Council of Science and Technology, Mexico; Psicofarma S.A. de C.V.完全的
-
AGO Study Group完全的
-
Morton Plant Mease Health CareOrtho Biotech Products, L.P.终止
-
Novacea未知
-
University of Magdeburg未知
-
Beth Israel Deaconess Medical CenterHarvard Risk Management Foundation; Dynamics Research Corporation; Armed Forces Institute of Pathology 和其他合作者完全的
-
Gustave Roussy, Cancer Campus, Grand ParisHoffmann-La Roche终止
-
University of MinnesotaAstraZeneca; Jensen, Jonathan B., M.D.完全的精神障碍 | 精神分裂症 | 分裂情感障碍 | 精神分裂症美国
-
Gustave Roussy, Cancer Campus, Grand Paris终止
-
Gustave Roussy, Cancer Campus, Grand Paris未知
-
Abbott完全的前列腺癌美国, 加拿大, 法国, 西班牙, 比利时, 澳大利亚, 英国, 意大利, 瑞典, 南非, 荷兰, 爱尔兰, 德国, 奥地利, 新西兰, 希腊, 波兰, 瑞士
-
Sheba Medical CenterJerusalem Mental Health Center未知
-
Korean Multiple Myeloma Working PartyCelgene Corporation未知
-
Amsterdam UMC, location VUmcBoehringer Ingelheim; Abbott未知
-
Rambam Health Care Campus完全的
-
Tripler Army Medical CenterU.S. Army Medical Research Acquisition Activity未知Mild, Moderate and Severe Persistent Asthma as Defined by NHLBI-2 Guidelines美国
-
BioCryst Pharmaceuticals完全的
-
Johann Wolfgang Goethe University HospitalGilead Sciences未知
-
Fachklinik Hornheide an der Universität Münster未知